212 related articles for article (PubMed ID: 18380584)
1. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.
Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC
Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs.
Royals SR; Farese JP; Milner RJ; Lee-Ambrose L; van Gilder J
Am J Vet Res; 2005 Nov; 66(11):1961-7. PubMed ID: 16334957
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
[TBL] [Abstract][Full Text] [Related]
4. Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
Nam A; Kim T; Li Q; Rebhun RB; Youn HY; Seo KW
J Vet Med Sci; 2019 Dec; 81(12):1722-1729. PubMed ID: 31645504
[TBL] [Abstract][Full Text] [Related]
5. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
6. Effects of lycopene on proliferation and death of canine osteosarcoma cells.
Wakshlag JJ; Balkman CE
Am J Vet Res; 2010 Nov; 71(11):1362-70. PubMed ID: 21034328
[TBL] [Abstract][Full Text] [Related]
7. 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines.
Massimini M; Palmieri C; De Maria R; Romanucci M; Malatesta D; De Martinis M; Maniscalco L; Ciccarelli A; Ginaldi L; Buracco P; Bongiovanni L; Della Salda L
Vet Pathol; 2017 May; 54(3):405-412. PubMed ID: 28438108
[TBL] [Abstract][Full Text] [Related]
8. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.
Farese JP; Ashton J; Milner R; Ambrose LL; Van Gilder J
In Vitro Cell Dev Biol Anim; 2004; 40(3-4):113-7. PubMed ID: 15311969
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Ludartin on Cell Proliferation, Cell Migration, Cell Cycle Arrest and Apoptosis Are Associated with Upregulation of p21WAF1 in Saos-2 Osteosarcoma Cells In Vitro.
Zhang SL; Li BL; Li W; Lu M; Ni LY; Ma HL; Meng QG
Med Sci Monit; 2018 Jul; 24():4926-4933. PubMed ID: 30008466
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
[TBL] [Abstract][Full Text] [Related]
12. Bupivacaine and Lidocaine Induce Apoptosis in Osteosarcoma Tumor Cells.
Mirshahidi S; Shields TG; de Necochea-Campion R; Yuan X; Janjua A; Williams NL; Mirshahidi HR; Reeves ME; Duerksen-Hughes P; Zuckerman LM
Clin Orthop Relat Res; 2021 Jan; 479(1):180-194. PubMed ID: 33009230
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of dihydroartemisinin on human osteosarcoma.
Ji Y; Zhang YC; Pei LB; Shi LL; Yan JL; Ma XH
Mol Cell Biochem; 2011 May; 351(1-2):99-108. PubMed ID: 21234653
[TBL] [Abstract][Full Text] [Related]
14. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines.
McCleese JK; Bear MD; Fossey SL; Mihalek RM; Foley KP; Ying W; Barsoum J; London CA
Int J Cancer; 2009 Dec; 125(12):2792-801. PubMed ID: 19544563
[TBL] [Abstract][Full Text] [Related]
15. The effects of sulforaphane on canine osteosarcoma proliferation and invasion.
Rizzo VL; Levine CB; Wakshlag JJ
Vet Comp Oncol; 2017 Sep; 15(3):718-730. PubMed ID: 27045198
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.
Mackowiak da Fonseca J; Mackowiak da Fonseca II; Nagamine MK; Massoco CO; Nishiya AT; Ward JM; Liu S; Leppla SH; Bugge TH; Dagli MLZ
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987941
[TBL] [Abstract][Full Text] [Related]
17. The second-generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells.
Kelly B; Thamm D; Rosengren RJ
Vet Comp Oncol; 2023 Dec; 21(4):595-604. PubMed ID: 37435770
[TBL] [Abstract][Full Text] [Related]
18. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
Ma K; Zhang C; Huang MY; Li WY; Hu GQ
Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
[TBL] [Abstract][Full Text] [Related]
19. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
Couto JI; Bear MD; Lin J; Pennel M; Kulp SK; Kisseberth WC; London CA
BMC Vet Res; 2012 Dec; 8():244. PubMed ID: 23244668
[TBL] [Abstract][Full Text] [Related]
20. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.
Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA
Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
